Literature DB >> 2505258

A repertoire of monoclonal antibodies with human heavy chains from transgenic mice.

M Brüggemann1, H M Caskey, C Teale, H Waldmann, G T Williams, M A Surani, M S Neuberger.   

Abstract

The introduction of human immunoglobulin gene segments in their unrearranged configuration into the germ line of mice might allow the production of a repertoire of human antibodies. Such transgenic mice could be used for the production of human monoclonal antibodies against human antigens. To test the feasibility of this approach, mice were created that carry a human heavy-chain minilocus comprising unrearranged immunoglobulin variable, diversity, and joining elements linked to a human mu-chain gene. The gene segments of this minilocus are rearranged in a large proportion of cells in thymus and spleen but not in nonlymphoid tissue. Some 4% of the B lymphocytes synthesize human mu chains resulting in a serum titer of about 50 micrograms of transgenic IgM antibody per ml. Hybridomas were established from the transgenic mice that stably secreted several micrograms of antibodies containing human mu heavy chains per milliliter.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505258      PMCID: PMC297915          DOI: 10.1073/pnas.86.17.6709

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  Human mAbs produced by primary in-vitro immunization.

Authors:  C A Borrebaeck
Journal:  Immunol Today       Date:  1988-11

2.  Replacing the complementarity-determining regions in a human antibody with those from a mouse.

Authors:  P T Jones; P H Dear; J Foote; M S Neuberger; G Winter
Journal:  Nature       Date:  1986 May 29-Jun 4       Impact factor: 49.962

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Rearrangement of a chicken immunoglobulin gene occurs in the lymphoid lineage of transgenic mice.

Authors:  D Bucchini; C A Reynaud; M A Ripoche; H Grimal; J Jami; J C Weill
Journal:  Nature       Date:  1987 Mar 26-Apr 1       Impact factor: 49.962

5.  A hapten-specific chimaeric IgE antibody with human physiological effector function.

Authors:  M S Neuberger; G T Williams; E B Mitchell; S S Jouhal; J G Flanagan; T H Rabbitts
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

6.  Rearrangement and expression of rabbit immunoglobulin kappa light chain gene in transgenic mice.

Authors:  M Goodhardt; P Cavelier; M A Akimenko; G Lutfalla; C Babinet; F Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Provision of the immunoglobulin heavy chain enhancer downstream of a test gene is sufficient to confer lymphoid-specific expression in transgenic mice.

Authors:  W Reik; G Williams; S Barton; M Norris; M Neuberger; M A Surani
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

8.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Authors:  S L Morrison; M J Johnson; L A Herzenberg; V T Oi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Reshaping human antibodies for therapy.

Authors:  L Riechmann; M Clark; H Waldmann; G Winter
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

10.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Transgenic animals and genetic engineering techniques. Nantes, France, 2-3 July, 2015.

Authors:  Séverine Ménoret; Laurent Tesson; Séverine Remy; Claire Usal; Laure-Hélène Ouisse; Lucas Brusselle; Vanessa Chenouard; Tuan H Nguyen; Laurent David; Ignacio Anegon
Journal:  Transgenic Res       Date:  2015-09-10       Impact factor: 2.788

Review 3.  Animal pharming, two decades on.

Authors:  Alexander Kind; Angelika Schnieke
Journal:  Transgenic Res       Date:  2008-07-29       Impact factor: 2.788

Review 4.  Antibody-cytokine fusion proteins: applications in cancer therapy.

Authors:  Elizabeth Ortiz-Sánchez; Gustavo Helguera; Tracy R Daniels; Manuel L Penichet
Journal:  Expert Opin Biol Ther       Date:  2008-05       Impact factor: 4.388

5.  Twenty years of combinatorial antibody libraries, but how well do they mimic the immunoglobulin repertoire?

Authors:  Mats A A Persson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

6.  A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibody.

Authors:  Paul W Fisher; Michael Brigham-Burke; Sheng-Jiun Wu; Jinquan Luo; Jill Carton; Kim Staquet; Wei Gao; Sheila Jackson; Deidra Bethea; Cailin Chen; Bing Hu; Jill Giles-Komar; Jing Yang
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

7.  Antibodies generated from human immunoglobulin miniloci in transgenic mice.

Authors:  S D Wagner; G T Williams; T Larson; M S Neuberger; D Kitamura; K Rajewsky; J Xian; M Brüggemann
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

8.  Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4.

Authors:  K Yoshinari; K Arai; H Kimura; K Matsumoto; Y Yamaguchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

Review 9.  Antibody engineering to develop new antirheumatic therapies.

Authors:  John D Isaacs
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

10.  A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins.

Authors:  L D Taylor; C E Carmack; S R Schramm; R Mashayekh; K M Higgins; C C Kuo; C Woodhouse; R M Kay; N Lonberg
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.